Publications by authors named "Julie Labonte"

Claim this Profile
C
Chymase inhibitor-sensitive synthesis of endothelin-1 (1-31) by recombinant mouse mast cell protease 4 and human chymase.
Walid Semaan, Louisane Desbiens, Martin Houde, Julie Labonté, Hugo Gagnon

Biochem Pharmacol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivotal role of mouse mast cell protease 4 in the conversion and pressor properties of Big-endothelin-1.
Martin Houde, Marc-David Jamain, Julie Labonté, Louisane Desbiens, Gunnar Pejler

J Pharmacol Exp Ther· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist.
Martin Savard, Julie Labonté, Céléna Dubuc, Witold Neugebauer, Pedro D'Orléans-Juste

Biol Chem· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide and non-peptide antagonists targeting endothelin receptors in physiology and pathology.
Martin Houde, Julie Labonté, Pedro D'Orléans-Juste

Curr Pharm Des· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct modulation of the endothelin-1 pathway in iNOS-/- and eNOS-/- mice.
Julie Labonté, Isabelle Brochu, Elie Simard, Pedro D'Orléans-Juste

Can J Physiol Pharmacol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant antagonism of endothelial and vascular smooth muscle cell ETB receptors for endothelin induces hypertension in the hamster.
Jean-Claude Honoré, Marie-Hélène Fecteau, Isabelle Brochu, Julie Labonté, Ghassan Bkaily

Am J Physiol Heart Circ Physiol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo.
Marie-Hélène Fecteau, Jean-Claude Honoré, Mirco Plante, Julie Labonté, Giles A Rae

Hypertension· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-engineered human vascular media with a functional endothelin system.
Karina Laflamme, Charles J Roberge, Julie Labonté, Stéphanie Pouliot, Pédro D'Orléans-Juste

Circulation· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced or repressed pressor responses to endothelin-1 or IRL-1620, respectively, in eNOS knockout mice.
Julie Labonté, Pedro D'Orléans-Juste

J Cardiovasc Pharmacol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis.
Jill C Rudkowski, Esther Barreiro, Rania Harfouche, Peter Goldberg, Osama Kishta, Julie Labonte

Am J Physiol Lung Cell Mol Physiol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular diseases: new insights from knockout mice.
Pedro D'Orléans-Juste, Jean-Claude Honoré, Emilie Carrier, Julie Labonté

Curr Opin Pharmacol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of endothelin receptors in the hypertensive state of kinin B(2) knockout mice subjected to a high-salt diet.
Isabelle Brochu, Julie Labonté, Ghassan Bkaily, Pedro D'Orléans-Juste

Clin Sci (Lond)· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis